Predict your next investment

Cryosa company logo
HEALTHCARE | Medical Devices & Equipment / Device Design & Manufacturing
cryosa.com

See what CB Insights has to offer

Founded Year

2014

Stage

Series A - II | Alive

Total Raised

$12.25M

Last Raised

$8.25M | 1 yr ago

About Cryosa

Cryosa is developing treatments for patients with sleep disordered breathing. It is developing a heat exchanger for causing cryolysis of adipose tissue of a human tongue. The heat exchanger includes a body having cooling channels for circulating fluids therein.

Cryosa Headquarter Location

2685 Long Lake Rd

Roseville, Minnesota, 55113,

United States

210-748-7121

Latest Cryosa News

Cryosa Completes $8.25 Million in Series A-2 Funding

Aug 27, 2020

Cryosa Completes $8.25 Million in Series A-2 Funding Money will be used to develop a minimally invasive treatment for obstructive sleep apnea. Business Wire08.27.20 Minnesota medical device startup Cryosa has completed its Series A-2 funding, raising $8.25 million to further develop its breakthrough therapies for obstructive sleep apnea (OSA). The round was led by life sciences firm, Santé Ventures, and HOYA Corporation, with additional institutional and individual investors. This latest funding round will be used to engage in first-in-human clinical trials. The company has completed extensive pre-clinical testing, evaluating safety and efficacy. “Current surgical treatments for obstructive sleep apnea are invasive and do not focus on curing the root cause of the disorder,” said Cryosa founder Dr. Donald Gonzales. “Cryosa was founded to develop minimally invasive, permanent therapies for OSA.”   OSA impacts approximately 22 million Americans, disrupting sleep and potentially leading to other serious medical conditions if undiagnosed and untreated. “There is a large, unmet medical need for a minimally invasive obstructive sleep apnea therapy,” said Dr. James Eadie, partner at Santé Ventures and Cryosa board member. “Cryosa’s approach is elegant and backed by a strong team of medical device entrepreneurs and engineers.”   “The market for OSA therapies is substantial and continues to grow,” said Rubal Bedi, global head and vice president of Corporate Venture Capital at HOYA. “Cryosa is well-positioned to help the needs of patients living with this sleep disorder.”   Cryosa was founded in 2018 by Gonzales, who also serves as the company’s chief medical officer (CMO). Prior to Cryosa, Gonzales was CMO for Entellus Medical, which was acquired by Stryker in 2018, and founded several other companies in the ear, nose and throat space including Spirox Medical and ENTrigue Surgical. Cryosa’s president and CEO is Mark Christopherson, who brings more than 25 years of experience in the medical device industry to the company. He was a co-founding executive of Inspire Medical and led NxThera's research and development during commercialization and pivotal trials, prior to the company’s acquisition by Boston Scientific in 2018. Obstructive sleep apnea occurs when the upper airway soft tissue collapses. Individuals with this sleep disorder may stop breathing for more than 10 seconds, experience lower oxygen saturation and be roused from sleep up to hundreds of times per night. “Recent research shows a connection between adipose/fat tissue of the upper airway and the severity of OSA,” Christopherson said. “By focusing on methods and treatments to selectively reduce adipose tissue, we believe we can help reduce instances of OSA and help people sleep better.”   PR Newswire 08.26.20 QIAGEN 08.26.20 Getinge 08.26.20 Business Wire 08.26.20 GlobeNewswire 08.26.20 GlobeNewswire 08.26.20 GlobeNewswire 08.26.20 Business Wire 08.26.20 Business Wire 08.26.20 PR Newswire 08.26.20 PR Newswire 08.25.20 Performance Motion Devices Inc. 08.25.20 B3C Newswire 08.25.20 Business Wire 08.25.20 Okami Medical Inc. 08.25.20

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cryosa

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cryosa is included in 2 Expert Collections, including Sleep Health & Wellness.

S

Sleep Health & Wellness

795 items

These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.

M

Medical Devices

8,341 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Cryosa Patents

Cryosa has filed 5 patents.

The 3 most popular patent topics include:

  • Abnormal respiration
  • Sleep disorders
  • Breathing abnormalities
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/16/2016

10/30/2018

Sleep disorders, Transcription factors, Abnormal respiration, Surgical removal procedures, Human head and neck

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

8/16/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

10/30/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Sleep disorders, Transcription factors, Abnormal respiration, Surgical removal procedures, Human head and neck

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Cryosa Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Cryosa Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.